Literature DB >> 6434628

Synthetic neoglycoproteins: a class of regents for detection of sugar-recognizing substances.

M Kataoka, M Tavassoli.   

Abstract

Specific interactions between proteins and sugars have recently been emphasized in many biological systems. To detect sugar-recognizing substances, known as lectin-like substances or endogenous lectins, we describe a method in which various sugars were covalently bound to a carrier protein such as albumin. This neoglycoprotein was stable at -20 degrees C for a period of 6 months. It was conjugated to various cytochemical markers (125I, fluorescein isothiocyanate, colloidal gold, or latex minibead). Detection of the marker then indicates the presence of the sugar-binding protein. Control experiments in the presence of unlabeled neoglycoprotein or specific sugar indicated the specificity of the reaction. This method was used to analyze the kinetics of binding for a mannose-recognition system in the mouse peritoneal macrophages. The data obtained were in agreement with those previously reported. The method can be used for detection of other sugar-recognizing systems as virtually every simple sugar can be bound to a carrier protein to produce these neoglycoproteins. Some of the consideration required for successful production of these reagents are discussed. These synthetic neoglycoproteins are useful in studying the distribution and kinetics of sugar-recognizing systems and may help to further our understanding of this rapidly developing area.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434628     DOI: 10.1177/32.10.6434628

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  11 in total

1.  Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA.

Authors:  N Oyaizu; N Chirmule; V S Kalyanaraman; W W Hall; R Pahwa; M Shuster; S Pahwa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Molecular basis of the recognition of intravenously transplanted hemopoietic cells by bone marrow.

Authors:  S Aizawa; M Tavassoli
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Characterization of membrane homing receptors in two cloned murine hemopoietic progenitor cell lines.

Authors:  T Matsuoka; C Hardy; M Tavassoli
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

4.  In vitro homing of hemopoietic stem cells is mediated by a recognition system with galactosyl and mannosyl specificities.

Authors:  S Aizawa; M Tavassoli
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

5.  Interaction of murine granulocyte-macrophage progenitors and supporting stroma involves a recognition mechanism with galactosyl and mannosyl specificities.

Authors:  S Aizawa; M Tavassoli
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

6.  Sugar-binding sites with specificity to N-acetyl-D-glucosaminides in middle ear mucosa of the guinea pig.

Authors:  F Tanimura; H Morioka
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

7.  Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones.

Authors:  N Oyaizu; N Chirmule; Y Ohnishi; V S Kalyanaraman; S Pahwa
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  Direct fluorescence localization of an endogenous N-acetyl-glucosamine-specific lectin in the thyroid gland.

Authors:  C Alquier; R Miquelis; M Monsigny
Journal:  Histochemistry       Date:  1988

9.  Mannose-mediated targeted immunoadjuvant action of liposomes.

Authors:  N Garcon; G Gregoriadis; M Taylor; J Summerfield
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

10.  Sugar-binding sites with specificity for glucosamine in the guinea pig middle ear mucosa.

Authors:  F Tanimura; H Morioka; Y Murakami
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.